Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 24 of 31
Ampyra for Optic Neuritis in Multiple Sclerosis
NCT01337986
Neurofibromatosis Type 1 Patient Registry
NCT01410006
Can Fish Oil and Phytochemical Supplements Mimic Anti-Aging Effects of Calorie Restriction?
NCT01752868
Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
NCT01207921
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
NCT01158118
Computer-Assisted Self-Interviews and Health Screening in the Pediatric Emergency Department
NCT01708317
Fat Metabolism in Pregnancy and Neonatal Heart Function in Diabetes
NCT01346527
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
NCT01006733
Progressive Weight Loss and Metabolic Health
NCT01299519
Cognitive Changes in Adult Cancer Survivors
NCT01569932
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
NCT00906945
Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability
NCT00889824
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
NCT01167192
Efficacy Study of Femoral Nerve Block in Children With a Femur Fracture
NCT01294098
Esophageal Cancer Tissue Banking
NCT01780961
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
NCT01133210
Cervical Foley Plus Vaginal Misoprostol for Labor Induction
NCT01279343
The Developmental Effects of NICU Positioning
NCT01628510
Does Protein Restriction Inhibit Prostrate Cancer Growth
NCT01692587
Early Warning System for Clinical Deterioration on General Hospital Wards
NCT01280942
Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot Study
NCT01272388
Propofol vs Propofol + Benzo/Opiates in High Risk Group
NCT01315158
PET Imaging of Endotoxin-induced iNOS Activation
NCT01407796
MRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer
NCT01060033
Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
NCT01161550
Catheter Placement for Hepatic Hydrothorax
NCT02595567
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
NCT00871702
Toward an Automated Method of Abdominal Fat Segmentation of MR Images
NCT01228968
Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia
NCT01137747
Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial
NCT01272960
Registry Study - Whipple at the Splenic Artery
NCT01155882
Nutritional Therapy for Diabetic Cardiomyopathy
NCT01373814
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
NCT01065129
The ACTIVE Intervention to Improve Hospice Care
NCT01211340
EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
NCT01000285
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
NCT01585129
Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
NCT01308944
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)
NCT01185275
Violence Prevention for Adolescent Girls With Prior Maltreatment
NCT02765048
Metabolically Normal and Metabolically Abnormal Obesity
NCT01184170
Assessment of Children With Tic Onset in the Past 6 Months
NCT01177774
Comparative Urine Proteomic Studies of Overactive Bladder in Humans
NCT01367886
Resting-State Neural Connectivity in Patients With Subjective Tinnitus Without Bother
NCT01049828
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
NCT01080248
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
NCT00949403
EUS-guided Fine Needle Aspiration (FNA) With and Without the Use of a Stylet
NCT01316614
Brain, Obesity, Dopamine and You Study
NCT01094756
Processing Speed as an Objective Measure of Tinnitus
NCT01222507
Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)
NCT01128413
Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
NCT01592058
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.